Navigation Links
AACR congratulates William S. Dalton on 2010 Leadership in Personalized Medicine Award
Date:10/21/2010

PHILADELPHIA The American Association for Cancer Research expresses its congratulations to and appreciation of William S. Dalton, M.D., Ph.D., who will receive the 2010 Leadership in Personalized Medicine Award from the Personalized Medicine Coalition (PMC).

Dalton, who has been a distinguished member of the AACR for more than 20 years, will receive the award from the PMC at the Harvard Personalized Medicine Conference on Nov. 17. According to the PMC, he is recognized for "his pioneering work putting the concepts of personalized medicine into practice for the benefit of patients."

Dalton is the chief executive officer of the H. Lee Moffitt Cancer Center in Tampa, Fla. He also serves as chair of the AACR's Science Policy and Legislative Affairs Committee.

"This is a wonderful and fitting honor for Dr. Dalton, who is at the forefront of personalized medicine and whose work has benefitted countless cancer patients," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "Moreover, Dr. Dalton's contributions extend beyond the lab and clinic to the halls of Congress. As chair of the AACR's Science Policy and Legislative Affairs Committee, he convenes the committee that guides the AACR's policy efforts. Dr. Dalton is a leader who is impacting the field on many levels, and we celebrate his achievement."

Dalton received his doctoral degree in toxicology and medical life sciences and his medical degree from Indiana University. He completed his internship in internal medicine at Indiana University, his residency in medicine at the University of Arizona in Tucson and his fellowships in oncology and clinical pharmacology at the University of Arizona. He is board certified in internal medicine and medical oncology and is an expert in multiple myeloma.

The PMC Award recognizes an individual whose contributions in science, business and/or policy have helped advance the frontiers of personalized medicine.


'/>"/>

Contact: Rachael Cullins
Rachael.Cullins@aacr.org
202-898-0668
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. GSA congratulates 2008 award winners
2. The American Association for Cancer Research congratulates Margaret Hamburg, M.D.
3. Elsevier congratulates Royal Australian Chemical Institutes Athel Beckwith Lectureship winner
4. The AACR congratulates its members elected to the Institute of Medicine
5. 2 genes influence social behavior, visual-spatial performance in people with Williams syndrome
6. AIUM presents 2009 William J. Fry Memorial Lecture award
7. Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVaults Board of Directors
8. University of Cincinnatis William Vanooij earns first Ohio Patent Award from Ohio Academy of Science
9. Christopher Marley and James McWilliams to give plenary speeches at Entomology 2010
10. Gender biases in leadership selection during competitions within and between groups
11. PNNL leadership in carbon sequestration featured at international conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... , March 28, 2017 Biostage, ... biotechnology company developing bioengineered organ implants to treat cancers ... trachea, today announced that Jim McGorry, CEO ... and BioEngineering panel at the MassBio 2017 ... 2:30 PM ET in Cambrige, Massachussetts. The 3D ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic ... time. A recent study published in STEM CELLS suggests that human neural stem ... stem cells to produce more neural cells. , Strategies involving transplantation of ...
(Date:3/28/2017)... , ... March 28, 2017 ... ... launch its brand-new, fully-certified hygienic SWB805 MultiMountTM weigh modules. These weigh modules ... and certified by National Sanitation Foundation (NSF). , As fully integrated weighing ...
(Date:3/28/2017)... ... March 28, 2017 , ... T3D ... a new orally administered treatment for Alzheimer’s disease (AD), today announced that Dr. ... “As we seek to uniquely treat the metabolic dysfunctions inherent in Alzheimer’s disease ...
Breaking Biology Technology: